220 related articles for article (PubMed ID: 22083596)
21. Field Cancerization in Sporadic Colon Cancer.
Park SK; Song CS; Yang HJ; Jung YS; Choi KY; Koo DH; Kim KE; Jeong KU; Kim HO; Kim H; Chun HK; Park DI
Gut Liver; 2016 Sep; 10(5):773-80. PubMed ID: 27114416
[TBL] [Abstract][Full Text] [Related]
22. Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).
Heigh RI; Yab TC; Taylor WR; Hussain FT; Smyrk TC; Mahoney DW; Domanico MJ; Berger BM; Lidgard GP; Ahlquist DA
PLoS One; 2014; 9(1):e85659. PubMed ID: 24465639
[TBL] [Abstract][Full Text] [Related]
23. A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening.
Zou H; Harrington J; Rego RL; Ahlquist DA
Clin Chem; 2007 Sep; 53(9):1646-51. PubMed ID: 17712002
[TBL] [Abstract][Full Text] [Related]
24. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
[TBL] [Abstract][Full Text] [Related]
25. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
Bosch LJ; Mongera S; Terhaar Sive Droste JS; Oort FA; van Turenhout ST; Penning MT; Louwagie J; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cell Oncol (Dordr); 2012 Aug; 35(4):309-15. PubMed ID: 22821210
[TBL] [Abstract][Full Text] [Related]
26. Detection of
Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.
Ausch C; Kim YH; Tsuchiya KD; Dzieciatkowski S; Washington MK; Paraskeva C; Radich J; Grady WM
Clin Chem; 2009 Aug; 55(8):1559-63. PubMed ID: 19541867
[TBL] [Abstract][Full Text] [Related]
28. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
Shinjo K; Hara K; Nagae G; Umeda T; Katsushima K; Suzuki M; Murofushi Y; Umezu Y; Takeuchi I; Takahashi S; Okuno Y; Matsuo K; Ito H; Tajima S; Aburatani H; Yamao K; Kondo Y
PLoS One; 2020; 15(6):e0233782. PubMed ID: 32520974
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection.
Xu H; Chen H; Hu J; Xiong Z; Li D; Wang S; Yu J
BMC Gastroenterol; 2022 Aug; 22(1):384. PubMed ID: 35963995
[TBL] [Abstract][Full Text] [Related]
30. Genetic and epigenetic markers in the evaluation of pancreatic masses.
Ginestà MM; Mora J; Mayor R; Farré A; Peinado MA; Busquets J; Serrano T; Capellá G; Fabregat J
J Clin Pathol; 2013 Mar; 66(3):192-7. PubMed ID: 23135349
[TBL] [Abstract][Full Text] [Related]
31. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
[TBL] [Abstract][Full Text] [Related]
32. BMP3 promoter hypermethylation in plasma-derived cell-free DNA in colorectal cancer patients.
Rokni P; Shariatpanahi AM; Sakhinia E; Kerachian MA
Genes Genomics; 2018 Apr; 40(4):423-428. PubMed ID: 29892846
[TBL] [Abstract][Full Text] [Related]
33. [Human stool vimentin, oncostatin M receptor and tissue factor pathway inhibitor 2 gene methylation analysis for the detection of colorectal neoplasms].
Zhang JP; Wang J; Gui YL; Zhu QQ; Xu ZW; Li JS
Zhonghua Yi Xue Za Zhi; 2011 Sep; 91(35):2482-4. PubMed ID: 22321844
[TBL] [Abstract][Full Text] [Related]
34. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.
Nagasaka T; Koi M; Kloor M; Gebert J; Vilkin A; Nishida N; Shin SK; Sasamoto H; Tanaka N; Matsubara N; Boland CR; Goel A
Gastroenterology; 2008 Jun; 134(7):1950-60, 1960.e1. PubMed ID: 18435933
[TBL] [Abstract][Full Text] [Related]
35. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass.
Maluf-Filho F; Kumar A; Gerhardt R; Kubrusly M; Sakai P; Hondo F; Matuguma SE; Artifon E; Monteiro da Cunha JE; César Machado MC; Ishioka S; Forero E
J Clin Gastroenterol; 2007; 41(10):906-10. PubMed ID: 18090159
[TBL] [Abstract][Full Text] [Related]
36. Co-amplification at lower denaturation-temperature PCR combined with unlabled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in plasma-circulating DNA of pancreatic adenocarcinoma cases.
Wu J; Zhou Y; Zhang CY; Song BB; Wang BL; Pan BS; Lou WH; Guo W
Asian Pac J Cancer Prev; 2014; 15(24):10647-52. PubMed ID: 25605154
[TBL] [Abstract][Full Text] [Related]
37. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.
Eshleman JR; Norris AL; Sadakari Y; Debeljak M; Borges M; Harrington C; Lin E; Brant A; Barkley T; Almario JA; Topazian M; Farrell J; Syngal S; Lee JH; Yu J; Hruban RH; Kanda M; Canto MI; Goggins M
Clin Gastroenterol Hepatol; 2015 May; 13(5):963-9.e4. PubMed ID: 25481712
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
Huang Z; Li L; Wang J
Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation biomarkers in stool for early screening of colorectal cancer.
Chen J; Sun H; Tang W; Zhou L; Xie X; Qu Z; Chen M; Wang S; Yang T; Dai Y; Wang Y; Gao T; Zhou Q; Song Z; Liao M; Liu W
J Cancer; 2019; 10(21):5264-5271. PubMed ID: 31602277
[No Abstract] [Full Text] [Related]
40. Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS.
Duan YF; Li DF; Liu YH; Mei P; Qin YX; Li LF; Lin QX; Li ZJ
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):204-9. PubMed ID: 23558076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
